ScanBalt celebrates its 10th anniversary

17.08.11 Under the motto “10 Years ScanBalt Bioregion – Towards a Balanced Regional Development and Smart Specialisation in the Baltic Sea Region”, the ScanBalt Bio­Region is holding the 10th ScanBalt Forum from September 21st-23rd.... more

Sanitas sells

11.06.11 Kaunas – US-based Valeant Pharmaceuticals International Inc. said in mid-May that it is purchasing an 87.2% share in Lithuanian generic drug maker Sanitas AB for EUR314m in cash, and will make a mandatory tender offer to acquire... more

Valeant Pharmaceutical Inc to bag Lithuanian Sanitas

25.05.11 Kaunas – US company Valeant Pharmaceuticals International, Inc. wants to purchase Lithuanian generic drug maker Sanitas AB for EUR314 million in cash. Shareholders of Sanitas have already agreed to sell Valeant 87.2% of Sanitas’... more

People with psoriasis have double risk of getting metabolic syndrome

21.12.10 Reykjavik – Individuals with psoriasis have a higher risk of developing metabolic syndrome than people without the skin disorder (Archives of Dermatology, 20 Dec.). Using data from 6,549 individuals who participated in the... more

Ministerial clash over GMO ban

03.11.10 Bucharest – Plans by Romanian Environment Minister Lazlo Borbely to implement a five-year ban on GMO acreage beginning next spring have been fiercely attacked by the country’s Agriculture Minister Valeriu Tabara. Borbely has... more